Telomerase is a ribonucleoprotein which facilitates the de novo synthesis of telomere ends. Because telomerase, with few exceptions, is found only in malignant cells, the enzyme points to new diagnostic and therapeutic perspectives. The biological growth pattern of prostatic carcinoma is variable. Beside the use of grading or the Gleason score as prognostic factors, it would also be useful to have a marker correlating with biologic growth patterns. This may also contribute to patients' therapeutic management. One such marker could be telomerase activity in prostate needle biopsies and ®ne needle aspiration cytology (FNAC) of the prostate. Telomerase activity could also serve in diagnostic decisionmaking in cases where evaluation of tissue samples is equivocal. Studies of tissue samples have shown that telemerase activity is present in 85±90% of cases of prostatic carcinoma, but not in samples obtained from patients with benign prostatic hyperplasia.
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This study aimed to determine whether determination of telomerase activity in prostate needle biopsies and FNACs is technically possible and of diagnostic relevant.
Method
Prostate needle biopsies were obtained at eight sites each of prostatectomy specimens from 20 patients presenting with prostatic carcinoma. Since the entire surgical specimen was evaluated histologically, the ®ndings could be correlated with the localization of the carcinoma. FNACs of the prostate were obtained in another 26 patients presenting with suspicion of prostatic carcinoma at the Inselspital in Bern. One half of each sample was studied by an experienced cytopathologist. The rest were examined for the presence of telomerase activity using the standard polymerase chain reaction (PCR)-based technique, the TRAP assay. We modi®ed the method for nonradioactive detection of TRAP products, while primers were end-marked with¯uorochrome.
Results
In 18 out of 20 patients (90%), telomerase activity was detected in material obtained from prostate needle biopsies. In 16 of these 18 patients, evidence of telomerase activity in prostate needle biopsies showed a correlation between the location of the biopsy site and localization of the carcinoma. In patients examined using FNACs, diagnosis made on the basis of ®ndings of cytology and detection of telomerase activity were in agreement in 21 out of 26 cases. In two cases telomerase activity was detected in samples with cytologically normal ®ndings, while in three other cases carcinoma cells observed at cytology were not associated with detectable telomerase activity.
Conclusion
Results of examinations of prostate needle biopsies and ®ne needle aspiration cytology for telomerase activity show that tumour cells can be identi®ed with a high degree of sensitivity using TRAP assays. In false-positive cases, corresponding to the examination of tumour margins, TRAP assay may have identi®ed individual tumour cells or precursors which escaped detection at histology.
To assess the precise diagnostic value of this method as an adjunct to histology or cytology, further studies are needed to show whether telomerase activity corresponds not only to the histopathologic classi®cation, but yields additional information about the malignant potential of the tumour under investigation.
